Early Stopping of a Clinical Trial When There is Evidence of No Treatment Benefit
- 22 December 1998
- journal article
- clinical trial
- Published by Elsevier in Controlled Clinical Trials
- Vol. 19 (6) , 575-588
- https://doi.org/10.1016/s0197-2456(98)00041-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Preliminary Results From the Cancer Research Campaign Trial Evaluating Tamoxifen Duration in Women Aged Fifty Years or Older With Breast CancerJNCI Journal of the National Cancer Institute, 1996
- Randomized Trial of Two Versus Five Years of Adjuvant Tamoxifen for Postmenopausal Early Stage Breast CancerJNCI Journal of the National Cancer Institute, 1996
- Five Versus More Than Five Years of Tamoxifen Therapy for Breast Cancer Patients With Negative Lymph Nodes and Estrogen Receptor-Positive TumorsJNCI Journal of the National Cancer Institute, 1996
- Stopping when the experimental regimen does not appear to helpStatistics in Medicine, 1994
- Bayesian Approaches to Randomized TrialsJournal of the Royal Statistical Society Series A: Statistics in Society, 1994
- Upper bounds for type I and type II error rates in conditional power calculationsCommunications in Statistics - Theory and Methods, 1990
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- Monitoring clinical trials: Conditional or predictive power?Controlled Clinical Trials, 1986
- Designs for group sequential testsControlled Clinical Trials, 1984
- An aid to data monitoring in long-term clinical trialsControlled Clinical Trials, 1982